BIT Capital’s Vir Biotechnology VIR Stock Holding History

BIT Capital’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$815K	Buy	80,000 +50,000	+167%	+$476K	0.02%	85
2026 Q1	$269K	Buy	+30,000	New	+$239K	0.01%	84
2023 Q2	–	Sell	-9,650	Closed	-$225K	–	174
2023 Q1	$225K	Buy	+9,650	New	+$247K	0.03%	108
2022 Q1	–	Sell	-40,000	Closed	-$1.67M	–	184
2021 Q4	$1.67M	Buy	+40,000	New	+$1.57M	0.13%	63

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT Capital's VIR Position: Q2 2026 in Review

BIT Capital increased its Vir Biotechnology (VIR) stake by 167% in Q2 2026, buying an estimated $476K and bringing the position to 80,000 shares worth $815K. The position accounts for 0.02% of the portfolio, ranked #85.

BIT Capital first reported a position in VIR in Q4 2021 and has held it in 4 quarters since. The position peaked at $1.67M in Q4 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

BIT Capital held 80,000 shares of Vir Biotechnology worth $815K as of Q2 2026.
BIT Capital bought 50,000 Vir Biotechnology shares in Q2 2026, an estimated $476K.
Vir Biotechnology made up 0.02% of BIT Capital's portfolio in Q2 2026, its #85 holding.
BIT Capital first reported a position in Vir Biotechnology in Q4 2021 and has held it in 4 quarters since.
BIT Capital's Vir Biotechnology position peaked at $1.67M in Q4 2021.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on BIT Capital's 13F filing for Q2 2026, filed 12 Aug 2026.